Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents

Linyi Wei, Qian Shi, Kenneth F. Bastow, Arnold Brossi, Susan L. Morris-Natschke, Kyoko Nakagawa-Goto, Tian Shung Wu, Shiow Lin Pan, Che Ming Teng, Kuo Hsiung Lee

研究成果: 雜誌貢獻文章

61 引文 斯高帕斯(Scopus)

摘要

C9-Substituted phenanthrene-based tylophorine derivatives (PBTs) (13-36) were synthesized and evaluated as in vitro anticancer agents against the human A549 lung cancer cell line. Twelve active compounds were further examined against DU-145 (prostate), ZR-751 (breast), KB (nasopharyngeal), and KB-Vin (multidrug resistant KB subline) human cancer cell lines. They showed potent cytotoxic activity against both wild type and matched multidrug resistant KB cell lines, and displayed notable selectivity toward DU-145 (prostate) and ZR-751 (breast) cancer cell lines. The mode of action of this class may be distinctly different from that of other cancer chemotherapeutic compounds. Three PBT analogs were also evaluated in a murine model. Compound 24b showed modest in vivo antitumor activity against human A549 xenograft in nude mice as well as potent in vitro cytotoxic activity, and thus, is a promising anticancer lead compound.
原文英語
頁(從 - 到)3674-3680
頁數7
期刊Journal of Medicinal Chemistry
50
發行號15
DOIs
出版狀態已發佈 - 七月 26 2007
對外發佈Yes

ASJC Scopus subject areas

  • Organic Chemistry

指紋 深入研究「Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents」主題。共同形成了獨特的指紋。

  • 引用此